US Bancorp’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $39K | Sell |
|
|||||
|
2025
Q2 | $103K | Sell |
|
|||||
|
2025
Q1 | $103K | Sell |
|
|||||
|
2024
Q4 | $149K | Sell |
|
|||||
|
2024
Q3 | $230K | Sell |
|
|||||
|
2024
Q2 | $290K | Sell |
|
|||||
|
2024
Q1 | $334K | Buy |
|
|||||
|
2023
Q4 | $323K | Buy |
|
|||||
|
2023
Q3 | $233K | Sell |
|
|||||
|
2023
Q2 | $332K | Buy |
|
|||||
|
2023
Q1 | $106K | Sell |
|
|||||
|
2022
Q4 | $140K | Sell |
|
|||||
|
2022
Q3 | $351K | Buy |
|
|||||
|
2022
Q2 | $495K | Sell |
|
|||||
|
2022
Q1 | $625K | Buy |
|
|||||
|
2021
Q4 | $631K | Sell |
|
|||||
|
2021
Q3 | $1.49M | Buy |
|
|||||
|
2021
Q2 | $1.5M | Sell |
|
|||||
|
2021
Q1 | $2.25M | Buy |
|
|||||
|
2020
Q4 | $2.07M | Buy |
|
|||||
|
2020
Q3 | $346K | Buy |
|
|||||
|
2020
Q2 | $9K | Buy |
|
|||||
|
2020
Q1 | $2K | Hold |
|
|||||
|
2019
Q4 | $2K | Sell |
|
|||||
|
2019
Q3 | $4K | Sell |
|
|||||
|
2019
Q2 | $11K | Hold |
|
|||||
|
2019
Q1 | $11K | Buy |
|
|||||
|
2018
Q4 | $3K | Sell |
|
|||||
|
2018
Q3 | $10K | Hold |
|
|||||
|
2018
Q2 | $10K | Buy |
|
|||||
|
2018
Q1 | $4K | Buy |
|
|||||
|
2017
Q4 | $1K | Buy |
|
|||||
|
2017
Q3 | $0 | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $8K | Sell |
|
|||||
|
2016
Q4 | $9K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $34K | Buy |
|
|||||
|
2016
Q1 | $31K | Sell |
|
|||||
|
2015
Q4 | $104K | Buy |
|
|||||
|
2015
Q3 | $83K | Buy |
|
|||||
|
2015
Q2 | $85K | Buy |
|